DrugPatentWatch Database Preview
CLINICAL TRIALS PROFILE FOR LIOTHYRONINE SODIUM
Clinical Trials for Liothyronine Sodium
Trial ID | Title | Status | Sponsor | Phase | Summary |
---|---|---|---|---|---|
NCT00004062 | Azacitidine to Restore Thyroid Function in Patients With Persistent or Metastatic Thyroid Cancer | Completed | National Cancer Institute (NCI) | Phase 1 | RATIONALE: Azacitidine may help thyroid cancer cells regain the ability to take up iodine. This would allow the cancer to be detected and treated by radioactive iodine. PURPOSE: Phase I trial to study the effectiveness of azacitidine to restore thyroid function in treating patients who have persistent or metastatic thyroid cancer. |
NCT00004062 | Azacitidine to Restore Thyroid Function in Patients With Persistent or Metastatic Thyroid Cancer | Completed | Lucille P. Markey Cancer Center at University of Kentucky | Phase 1 | RATIONALE: Azacitidine may help thyroid cancer cells regain the ability to take up iodine. This would allow the cancer to be detected and treated by radioactive iodine. PURPOSE: Phase I trial to study the effectiveness of azacitidine to restore thyroid function in treating patients who have persistent or metastatic thyroid cancer. |
NCT00027417 | Study of Triostat in Infants During Heart Surgery | Completed | Michael Portman | Phase 3 | This is a study to determine the safety and efficacy of liothyronine sodium/triiodothyronine (Triostat), a synthetic thyroid hormone, when given to infants with congenital heart disease during cardiopulmonary bypass surgery. |
Trial ID | Title | Status | Sponsor | Phase | Summary |
Clinical Trial Conditions for Liothyronine Sodium
Condition Name
Condition MeSH
Clinical Trial Locations for Liothyronine Sodium
Trials by Country
Clinical Trial Progress for Liothyronine Sodium
Clinical Trial Phase
Clinical Trial Sponsors for Liothyronine Sodium
Sponsor Name